NO132593B - - Google Patents
Download PDFInfo
- Publication number
- NO132593B NO132593B NO742863A NO742863A NO132593B NO 132593 B NO132593 B NO 132593B NO 742863 A NO742863 A NO 742863A NO 742863 A NO742863 A NO 742863A NO 132593 B NO132593 B NO 132593B
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- mol
- propyl
- phenyl
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 150000007514 bases Chemical class 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 48
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 36
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 34
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 34
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- 238000002844 melting Methods 0.000 description 25
- 230000008018 melting Effects 0.000 description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 24
- 239000002904 solvent Substances 0.000 description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- 239000002585 base Substances 0.000 description 15
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 239000007789 gas Substances 0.000 description 12
- 150000003840 hydrochlorides Chemical class 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- XCMISAPCWHTVNG-UHFFFAOYSA-N 3-bromothiophene Chemical compound BrC=1C=CSC=1 XCMISAPCWHTVNG-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 4
- TUCRZHGAIRVWTI-UHFFFAOYSA-N 2-bromothiophene Chemical compound BrC1=CC=CS1 TUCRZHGAIRVWTI-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- -1 isopropyl HCl Chemical compound 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000003788 cerebral perfusion Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229960000395 phenylpropanolamine Drugs 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QBCICFNKXBQWLN-UHFFFAOYSA-N 1-thiophen-3-ylpropan-1-one Chemical compound CCC(=O)C=1C=CSC=1 QBCICFNKXBQWLN-UHFFFAOYSA-N 0.000 description 1
- RNIDWJDZNNVFDY-UHFFFAOYSA-N 3-Acetylthiophene Chemical compound CC(=O)C=1C=CSC=1 RNIDWJDZNNVFDY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical class CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- OEJCCWIXUKNQRW-UHFFFAOYSA-N [Li]C=1C=CSC=1 Chemical compound [Li]C=1C=CSC=1 OEJCCWIXUKNQRW-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000001490 effect on brain Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000009090 positive inotropic effect Effects 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691921453 DE1921453C3 (de) | 1969-04-26 | 1969-04-26 | Basische Dithienylderivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO132593B true NO132593B (it) | 1975-08-25 |
NO132593C NO132593C (it) | 1975-12-03 |
Family
ID=5732538
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO142270A NO131675C (it) | 1969-04-26 | 1970-04-15 | |
NO742863A NO132593C (it) | 1969-04-26 | 1974-08-08 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO142270A NO131675C (it) | 1969-04-26 | 1970-04-15 |
Country Status (16)
Country | Link |
---|---|
AT (2) | AT307399B (it) |
BE (1) | BE749296A (it) |
CH (1) | CH539645A (it) |
DE (1) | DE1921453C3 (it) |
DK (1) | DK126001B (it) |
EG (1) | EG10650A (it) |
ES (2) | ES377719A1 (it) |
FI (1) | FI50125C (it) |
FR (1) | FR2042377B1 (it) |
GB (1) | GB1296112A (it) |
IT (1) | IT1043819B (it) |
NL (1) | NL149174B (it) |
NO (2) | NO131675C (it) |
SE (1) | SE369305B (it) |
SU (1) | SU457221A3 (it) |
TR (1) | TR17649A (it) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE394280B (sv) * | 1970-04-17 | 1977-06-20 | Degussa | Forfarande for framstellning av basiskt substituerade ditienylderivat |
JPS5033063B1 (it) * | 1971-01-19 | 1975-10-27 | ||
GB1579541A (en) * | 1977-01-12 | 1980-11-19 | Degussa | Process for the production of (1,1 - dithien - (3)-yl - 1 - hydroxy - (3) - propyl) - (1-phenyl - 1 - hydroxy - (2) - propyl)-amine and (1,1 - dithien - (3) - yl-(1) - propen - (3) - yl) - (1 - phenyl-1 - hydroxy - (2) - propyl)- amine |
GB1597591A (en) * | 1977-01-12 | 1981-09-09 | Degussa | Dithienyl alkylamines and alkenylamines and a process for their production |
US4278687A (en) | 1980-01-31 | 1981-07-14 | Shell Oil Company | Inhibition of biosynthesis of triglycerides by certain N-β-phenethyl-N-thienylalkylamines |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2561899A (en) * | 1948-02-25 | 1951-07-24 | Burroughs Wellcome Co | Dithienyl allyl amines |
DE874914C (de) * | 1950-04-28 | 1953-04-27 | Wellcome Found | Verfahren zur Herstellung von Thienylverbindungen |
DE964056C (de) * | 1955-09-25 | 1957-05-16 | Basf Ag | Verfahren zur Herstellung von Thiophenderivaten |
DE1219038B (de) * | 1962-12-08 | 1966-06-16 | Degussa | Verfahren zur Herstellung von Thiophenverbindungen |
DE1199783B (de) * | 1962-11-30 | 1965-09-02 | Degussa | Verfahren zur Herstellung von basischen Thiophenderivaten |
DE1194424B (de) * | 1961-11-10 | 1965-06-10 | Degussa | Verfahren zur Herstellung von basischen Thiophenderivaten |
DE1217967B (de) * | 1962-12-08 | 1966-06-02 | Degussa | Verfahren zur Herstellung von basischen Thiophenderivaten |
DE1217396B (de) * | 1963-07-04 | 1966-05-26 | Laboratorie Roger Bellon, Neuilly-sur-Seine (Frankreich) | Verfahren zur Herstellung von 1 - (Thienyl-21) - l-oxo-2-amino-propanen |
AT255400B (de) * | 1965-03-22 | 1967-07-10 | Chemie Linz Ag | Verfahren zur Herstellung von neuen basischen Äthern |
FR1462206A (fr) * | 1965-06-08 | 1966-04-15 | Innothera Lab Sa | Composés gem-bithiényliques et leur préparation |
-
1969
- 1969-04-26 DE DE19691921453 patent/DE1921453C3/de not_active Expired
-
1970
- 1970-03-11 CH CH359770A patent/CH539645A/de not_active IP Right Cessation
- 1970-03-20 FI FI80070A patent/FI50125C/fi active
- 1970-03-20 ES ES377719A patent/ES377719A1/es not_active Expired
- 1970-03-26 NL NL7004410A patent/NL149174B/xx not_active IP Right Cessation
- 1970-04-15 NO NO142270A patent/NO131675C/no unknown
- 1970-04-17 GB GB1296112D patent/GB1296112A/en not_active Expired
- 1970-04-17 SU SU1437303A patent/SU457221A3/ru active
- 1970-04-21 BE BE749296D patent/BE749296A/xx not_active IP Right Cessation
- 1970-04-21 TR TR1764970A patent/TR17649A/xx unknown
- 1970-04-23 DK DK210370A patent/DK126001B/da not_active IP Right Cessation
- 1970-04-24 IT IT5026170A patent/IT1043819B/it active
- 1970-04-24 AT AT293571A patent/AT307399B/de not_active IP Right Cessation
- 1970-04-24 AT AT377570A patent/AT303716B/de not_active IP Right Cessation
- 1970-04-24 SE SE571370A patent/SE369305B/xx unknown
- 1970-04-24 FR FR7015055A patent/FR2042377B1/fr not_active Expired
-
1971
- 1971-07-17 EG EG31571A patent/EG10650A/xx active
-
1972
- 1972-01-11 ES ES398738A patent/ES398738A1/es not_active Expired
-
1974
- 1974-08-08 NO NO742863A patent/NO132593C/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO131675C (it) | 1975-07-09 |
CH539645A (de) | 1973-07-31 |
DE1921453B2 (de) | 1972-09-28 |
AT307399B (de) | 1973-05-25 |
FR2042377B1 (it) | 1974-02-01 |
EG10650A (en) | 1976-03-31 |
SE369305B (it) | 1974-08-19 |
NO131675B (it) | 1975-04-01 |
SU457221A3 (ru) | 1975-01-15 |
FR2042377A1 (it) | 1971-02-12 |
GB1296112A (it) | 1972-11-15 |
BE749296A (fr) | 1970-10-01 |
ES398738A1 (es) | 1974-08-16 |
NL149174B (nl) | 1976-04-15 |
NO132593C (it) | 1975-12-03 |
FI50125C (fi) | 1975-12-10 |
ES377719A1 (es) | 1972-10-16 |
AT303716B (de) | 1972-12-11 |
IT1043819B (it) | 1980-02-29 |
DE1921453A1 (de) | 1970-11-12 |
NL7004410A (it) | 1970-10-28 |
FI50125B (it) | 1975-09-01 |
TR17649A (tr) | 1975-07-23 |
DK126001B (da) | 1973-05-28 |
DE1921453C3 (de) | 1973-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3420851A (en) | Novel dibenzoxepines | |
NO800222L (no) | Engangsbleie. | |
US3957850A (en) | Phenylacetic acid derivatives | |
NO834637L (no) | Fremgangsmaate ved fremstilling av nye tieno(2,3-6)-pyrrolderivater | |
NO157503B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive azepinderivater. | |
NO153001B (no) | Drivanordning for skip | |
US2489236A (en) | Synthesis of biotin and related compounds | |
NO132593B (it) | ||
IL33582A (en) | Basic aryloxyacetamides,their preparation and pharmaceutical compositions containing them | |
NO119801B (it) | ||
NO750819L (it) | ||
NO162907B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bis-(piperazinyl-resp. homopiperazinyl)-alkaner. | |
US4159986A (en) | Novel thiophene-acetic acids | |
IL28432A (en) | New fantasy histories of the tetracycline type and processes for their preparation | |
US6545149B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
CN106866663A (zh) | 一种吡喹酮合成的工艺方法 | |
US3821241A (en) | 1-imidazolyl-2-substituted hydroxy propyl amines | |
US3766173A (en) | Basic dithienyl compounds | |
US3390179A (en) | Novel 10, 11-dihydro-10, 11-dihydroxy-(3-substituted aminopropylidene)-5h-dibenzo [a, d] cycloheptenes | |
NO743347L (it) | ||
US3583997A (en) | Benzothiopyrano(2,3-c)pyridines | |
PL80814B1 (en) | Hydroxyethano-anthracenes[us3706765a] | |
NO131834B (it) | ||
NO131345B (it) | ||
US3475438A (en) | Piperidine derivatives of dibenzobicyclo(5.1.0)octane |